Cargando…
Review of Trials Currently Testing Stem Cells for Treatment of Respiratory Diseases: Facts Known to Date and Possible Applications to COVID-19
Therapeutic clinical and preclinical studies using cultured cells are on the rise, especially now that the World Health Organization (WHO) declared coronavirus disease 2019 (COVID-19) a “public health emergency of international concern”, in January, 2020. Thus, this study aims to review the outcomes...
Autores principales: | Majolo, Fernanda, da Silva, Guilherme Liberato, Vieira, Lucas, Timmers, Luís Fernando Saraiva Macedo, Laufer, Stefan, Goettert, Márcia Inês |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442550/ https://www.ncbi.nlm.nih.gov/pubmed/32827081 http://dx.doi.org/10.1007/s12015-020-10033-6 |
Ejemplares similares
-
Neuropsychiatric Disorders and COVID-19: What We Know So Far
por: Majolo, Fernanda, et al.
Publicado: (2021) -
c-Jun N-Terminal Kinase Inhibitors as Potential Leads for New Therapeutics for Alzheimer’s Diseases
por: Hepp Rehfeldt, Stephanie Cristine, et al.
Publicado: (2020) -
A Special View of What Was Almost Forgotten: p38δ MAPK
por: Anton, Débora Bublitz, et al.
Publicado: (2021) -
Neural regeneration research model to be explored: SH-SY5Y human neuroblastoma cells
por: Hoffmann, Lavynia Ferreira, et al.
Publicado: (2022) -
SARS-CoV-2 mutations in Brazil: from genomics to putative clinical conditions
por: Timmers, Luis Fernando Saraiva Macedo, et al.
Publicado: (2021)